From infection to autoimmunity

Journal of Autoimmunity

Volumn 16, Issue 3, 2001, Pages 175-186

  Fairweather, Delisa ^a   Kaya, Ziya ^a   Shellam, Geoffrey R ^b   Lawson, Cassandra M ^c   Rose, Noel R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

Autoimmunity; Innate immunity; Myocarditis; Review

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENT; COMPLEMENT RECEPTOR; MYOSIN; MYOSIN ANTIBODY; VIRUS ANTIGEN;

ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; IMMUNOPATHOGENESIS; INFECTION; INFECTION SENSITIVITY; MOLECULAR MIMICRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS;

EID: 0034984260     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0492     Document Type: Conference Paper

References (98)

1. Molecular mimicry: A critical look at exemplary instances in human diseases
2. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis
3. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease
4. Molecular mimicry between a viral peptide and a myelin oligodenrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice
5. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection
6. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/ ++ mice and induces partial tolerance against Coxsackieviral myocarditis
7. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: A model for the study of molecular mimicry in the pathogenesis of viral myocarditis
8. Myocarditis - From infection to autoimmunity
9. Myocarditis
10. The pathogenesis of dilated cardiomyopathy
11. Infectious myocarditis and dilated cardiomyopathy
12. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future
13. The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy
14. A genetic map of autoimmune heart disease
15. Autoimmunity in myocarditis: Relevance of animal models
16. Myocarditis: The Dallas criteria
17. A clinicopathologic description of myocarditis
18. Replication, molecular biology and pathogenesis of coxsackieviruses
19. Picornaviruses
20. The family Herpesviridae: An update
21. Enteroviruses and myocarditis: Viral pathogenesis through replication, cytokine induction and immunopathogenicity
22. Age-dependent pathogenecity of group B coxsackieviruses in Swiss-Webster mice
23. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during coxsackievirus B3 infection
24. Characterisation and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains
25. Variations in the susceptibility of coxsackievirus B3-induced myocarditis among different strains of mice
26. Genetic control of mouse cytomegalovirus-induced myocarditis
27. Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice. Characterization of infiltrating cells
28. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin
29. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)
30. Persistence of virus and viral genome in myocardium after Coxsackievirus B3-induced murine myocarditis
31. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury
32. The role of enterovirus replication in the development of acute and chronic muscle disease in different immunocompetent mouse strains
33. Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis
34. Innate immunity-beginning to fulfill its promise?
35. The role of T cells in mouse cytomegalovirus induced myocarditis
36. The role of T cells in CoxsackieB-induced disease
37. Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease
38. Myocardial changes after infection with coxsackievirus B3 in nude mice
39. + cytolytic lymphocytes
40. + T lymphocytes in Coxsackievirus B3-induced myocarditis
41. The pathogenesis of postinfectious myocarditis
42. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin
43. Coxsackievirus induced myocarditis in mice: Cardiac myosin autoantibodies do not cross-react with the virus
44. Coxsackievirus B3 myocarditis: Identification of different pathogenic mechanisms in DBA/2 and BALB/c mice
45. Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity
46. Augmentation of pathogenesis of Coxsackievirus infections in mice by exogenous administration of interleukin-1 and interleukin-2
47. Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis?
48. LPS promotes CB3-induced myocarditis in resistant B10.A mice
49. Interleukin 1 or tumor necrosis factor can promote Coxsackievirus B3-induce myocarditis in resistant B10.A mice
50. Dependence of the adaptive immune response on innate immunity: Some questions answered but new paradoxes emerge
51. The instructive role of innate immunity in the acquired immune response
52. Phylogenetic perspectives in innate immunity
53. Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection
54. Linkages of innate and adaptive immunity
55. Natural interferon α/β-producing cells link innate and adaptive immunity
56. The role of complement in the induction of antibody responses
57. The role of complement and complement receptors in induction and regulation of immunity
58. Decay-accelerating factor: Biochemistry, molecular biology, and function
59. Identification and biology of cellular receptors for the Coxsackie B viruses group
60. Complement component 3 interactions with Coxsackievirus B3 capsid proteins: Innate immunity and the rapid formation of splenic antiviral germinal centers
61. Cardiovirulent Coxsackieviruses and the decay-accelerating factor (CD55) receptor
62. lck is essential in Coxsackievirus B3-mediated heart disease
63. Inhibitory MHC class I receptors on NK cells and T cells
64. Natural killer cells and natural killer T cells
65. Murine natural killer cells limit Coxsackievirus B3 replication
66. The role of natural killer cells in innate resistance to infection
67. Control of infections by NK cells
68. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways
69. Coordinated events during bacteria-induced DC maturation
70. Characterization of early IL-12, INF-αβ and TNF effects on antiviral state and NK cells responses during murine cytomegalovirus infection
71. NK cell proliferation and inflammation
72. Arousal and inhibition of human NK cells
73. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis
74. The immunoregulatory effects of NK cells: The role of TGF-β and implications for autoimmunity
75. Perforin-mediated myocardial damage in acute myocarditis
76. Mechanisms for virus-induced liver disease: Tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection
77. r mouse: A strain congenic for Cmv1 and the NK gene complex
78. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6
79. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection
80. Pancreatic expression of interferon-γ protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis
81. Immune regulation: A critical link between NK cells and CTLs
82. The role of self-recognition in receptor repertoire development
83. Natural killer cells determine the outcome of B cell-mediated autoimmunity
84. Regulation of immune responses by TGF-β
85. C3d of complement as a molecular adjuvant: Bridging innate and adaptive immunity
86. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
87. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs
88. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide
89. Cutting Edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
90. Triggering of murine NK cells by CD40 and CD86 (B7-2)
91. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection
92. Role of interferons and other cytokines in the regulation of the immune response
93. In vivo expression of an interferon-α gene by intramuscular injection of naked DNA
94. Antiviral activities of individual murine IFN-α subtypes in vivo: Intramuscular injection of IFN expression constructs reduces cytomegalovirus replication
95. Abrogation of TGF-β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
96. The forces driving autoimmune disease
97. Approaching the asymptote? Evolution and revolution in immunology
98. Cutting Edge Commentary: Immune responses in the absence of costimulation: Viruses know the trick